Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
CVbskj94FwUQN4Nq
